The Georgia Research Alliance (GRA) expands research and commercialization capacity in Georgia’s universities to launch new companies,
Business Model:
Revenue: $500M
Employees: 51-200
Address: 270 Peachtree Street NW
City: Atlanta
State: GA
Zip: 30303
Country: US
The Georgia Research Alliance (GRA) expands research and commercialization capacity in Georgia’s universities to launch new companies, create high-value jobs and transform lives. Since its formation in 1990, GRA has leveraged over $600 million of state funding into: $2.6 billion of direct federal and private investment in Georgia 150+ newly launched companies 6,000+ high-skill, high-value jobs a portfolio of inventions, processes and technologies that benefit humankind GRA is an independent nonprofit (501c3) organization closely aligned with Georgia’s Department of Economic Development and works with the following partner universities: University of Georgia, Georgia Regents University, Emory University, Clark Atlanta University, Georgia Institute of Technology, Georgia State University, Mercer University and Morehouse School of Medicine.
Contact Phone:
+14043329770
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
11/2013 | MedShape | Seed Round | - |
5/2015 | MetCure Therapeutics | Grant | - |
12/2008 | Velocity Medical Solutions | Grant | 150k |
6/2018 | Oncospherix | Grant | 53.4k |
7/2018 | PNP Therapeutics | Grant | 50k |
1/2018 | Celtaxsys | Series E | - |
2/2019 | Pyrefin | Grant | 48.1k |
7/2016 | RePredix | Grant | 44k |
8/2009 | Inhibikase Therapeutics | Grant | 50k |
6/2017 | BioPace | Grant | 30.3k |
3/2019 | Abby Med | Grant | 50.6k |
10/2014 | Abby Med | Grant | 110k |
11/2008 | Inhibikase Therapeutics | Grant | 55.6k |
1/2016 | Corami Therapeutics | Grant | 58.2k |
4/2012 | Cambium Medical Technologies | Grant | 25k |
2/2019 | Cognition Medical | Grant | 66k |
1/2018 | Centizyme | Grant | 35.2k |
1/2011 | Whisper Communications | Grant | 48k |
1/2019 | Neovaccine Strategies | Grant | 50k |
9/2013 | QUE Oncology | Grant | 119k |
2/2013 | QUE Oncology | Grant | 25k |
10/2012 | QUE Oncology | Grant | 25k |
7/2014 | QUE Oncology | Grant | 98.9k |
5/2014 | NovAb | Grant | 50k |
5/2017 | Nutrivert | Grant | 23.8k |
12/2012 | NovAb | Grant | 25k |
7/2007 | Velocity Medical Solutions | Grant | 100k |
11/2010 | NeurOp | Grant | 150k |
3/2005 | NeurOp | Grant | 50k |
10/2011 | NeurOp | Grant | 100k |
11/2015 | TendoNova | Grant | 49.3k |
8/2017 | TendoNova | Grant | 43.6k |
3/2019 | TendoNova | Grant | 36k |
7/2014 | CloudTags | Grant | 15k |
5/2014 | Cambium Medical Technologies | Grant | 60k |
9/2017 | NatGlycan | Grant | 25k |
1/2007 | Velocity Medical Solutions | Grant | 50k |
12/2005 | Velocity Medical Solutions | Grant | 50k |
3/2017 | DIASYST Inc. | Grant | 50k |
3/2019 | Sequegenics | Grant | 32.5k |
4/2015 | LymphaTech | Seed Round | - |
7/2016 | MoQuality | Grant | 275k |
10/2011 | Cambium Medical Technologies | Grant | 25k |
3/2014 | Sanguina | Grant | 25k |
2/2019 | Lucid Scientific | Grant | 26.4k |
4/2016 | NovAb | Grant | 100k |
5/2018 | PDx Scan | Grant | 17.5k |
5/2017 | Sanguina | Grant | 61k |
4/2016 | Nyra Medical | Grant | 20k |
2/2013 | Sanguina | Grant | 13k |
4/2009 | NeurOp | Grant | 50k |
1/2012 | AKESOgen | Grant | 150k |
9/2013 | Behavioral Science Technologies | Grant | 22.8k |
7/2014 | Nyra Medical | Grant | 52.3k |
10/2011 | Nyra Medical | Grant | 10k |
12/2014 | NovAb | Grant | 150k |
4/2012 | NovAb | Grant | 25k |
3/2018 | RePredix | Grant | 36k |
3/2020 | Aviabiotic | Grant | 0 |
8/2005 | NeurOp | Grant | 50k |
8/2018 | Centizyme | Grant | 10k |
12/2016 | Covanos | Grant | 49.9k |
1/2015 | CloudTags | Grant | 75k |
2/2011 | AKESOgen | Grant | 50k |
10/2011 | AKESOgen | Grant | 100k |
9/2014 | AlphaStem | Grant | 82.7k |
7/2012 | AlphaStem | Grant | 4k |
3/2016 | DIASYST Inc. | Grant | 50k |
11/2022 | Nyra Medical | Series A | 20M |
10/2009 | Inhibikase Therapeutics | Grant | 50k |
3/2017 | Urjanet | Series C | 0 |
11/2022 | Nyra Medical | Series A | 0 |
10/2017 | Abby Med | Grant | 40.6k |
8/2019 | HAWA Therapeutics | Seed Round | 25k |
2/2017 | Sophia Bioscience | Grant | 59.2k |
11/2017 | Centizyme | Grant | 10k |
9/2014 | Clearside Biomedical | Series B | 16M |
11/2018 | Antios Therapeutics | Series A | 0 |
12/2006 | Velocity Medical Solutions | Grant | 25k |
7/2017 | RePredix | Grant | 25k |
8/2019 | Pyrefin | Grant | 52.6k |
8/2019 | Proxime | Grant | 40.1k |
2/2018 | Proxime | Grant | 27k |
2/2019 | Aviabiotic | Grant | 30k |
4/2018 | BioPace | Grant | 54.5k |
4/2019 | Oncospherix | Grant | 41.6k |
11/2019 | PNP Therapeutics | Grant | 50k |
11/2011 | Metaclipse Therapeutics | Grant | 25k |
3/2014 | AngioCloud | Grant | 54.4k |
3/2020 | Neovaccine Strategies | Grant | 0 |
2/2020 | Focused Cryo | Grant | 0 |
9/2016 | Nyra Medical | Grant | 74.9k |
1/2012 | Nyra Medical | Grant | 25k |
1/2020 | Nyra Medical | Grant | 0 |
9/2008 | Inhibikase Therapeutics | Grant | 25k |
2/2018 | Oncospherix | Grant | 22.4k |
7/2017 | NanoV Therapeutics | Grant | 24.8k |
2/2020 | Focused Cryo | Grant | 0 |
1/2019 | Migra Therapeutics | Grant | 51.7k |
8/2016 | CellectCell | Grant | - |
10/2015 | CellectCell | Grant | - |
6/2016 | MicroBplex | Grant | 100k |
7/2010 | Inhibikase Therapeutics | Grant | 150k |
11/2008 | Inhibikase Therapeutics | Grant | 25k |
12/2019 | Focused Cryo | Grant | 0 |
11/2017 | Covanos | Grant | 39k |
12/2015 | Covanos | Grant | 80.5k |
3/2018 | Covanos | Grant | 40k |
11/2015 | Accuitis | Seed Round | 0 |
2/2018 | Cognition Medical | Grant | 84k |
9/2014 | RSV NewCo | Grant | 50k |
9/2017 | MicroBplex | Grant | 50.7k |
5/2014 | MicroBplex | Grant | 73k |
7/2012 | MicroBplex | Grant | 25k |
7/2018 | BioPace | Grant | 105.2k |
7/2010 | Iconic Therapeutics | Grant | 100k |
3/2018 | Migra Therapeutics | Grant | 35.8k |
12/2016 | Neurotrack | Grant | 800k |
3/2014 | Abby Med | Grant | 34k |
3/2016 | Sequegenics | Grant | 47.5k |
4/2010 | Iconic Therapeutics | Grant | 150k |
1/2010 | Iconic Therapeutics | Grant | 50k |
1/2016 | Codoxo | Grant | 0 |
7/2019 | Kodikaz Therapeutic Solutions | Grant | 50k |
7/2012 | Sanguina | Grant | 25k |
1/2020 | BioData Consortium | Grant | 20k |
4/2017 | Corami Therapeutics | Grant | 29.9k |
5/2015 | Corami Therapeutics | Grant | 11.8k |
10/2017 | Corami Therapeutics | Grant | 41.9k |
7/2019 | BioData Consortium | Grant | 25k |
3/2017 | Sequegenics | Grant | 65k |
8/2009 | Iconic Therapeutics | Grant | 48k |
9/2011 | Inhibikase Therapeutics | Grant | 100k |
3/2016 | Sanguina | Grant | 81k |
9/2017 | Reservoir | Grant | 25k |
7/2019 | Lucid Scientific | Grant | 58.5k |
6/2018 | Lucid Scientific | Grant | 23.9k |
9/2006 | Velocity Medical Solutions | Grant | 50k |
7/2015 | QUE Oncology | Grant | 150k |
11/2015 | QUE Oncology | Grant | 100k |
12/2016 | NatGlycan | Grant | 25k |
6/2017 | Covanos | Grant | 75k |
7/2012 | Metaclipse Therapeutics | Grant | 57.5k |
4/2012 | Metaclipse Therapeutics | Grant | 42k |
11/2010 | Metaclipse Therapeutics | Grant | 25k |
6/2016 | DIASYST Inc. | Grant | 50k |
9/2006 | NeurOp | Grant | 25k |
1/2011 | AKESOgen | Grant | 50k |
6/2011 | LiquidText | Grant | - |
1/2019 | DIASYST Inc. | Grant | 50k |
3/2020 | AngioCloud | Grant | 34.3k |
2/2022 | EarliTec Diagnostics | Series A | 19.5M |
9/2019 | TendoNova | Grant | 69k |
8/2021 | TendoNova | Seed Round | 250k |
1/2019 | MapHabit | Grant | 48.4k |
10/2018 | MapHabit | Grant | 58.5k |
2/2022 | EarliTec Diagnostics | Series A | 0 |
3/2020 | Aviabiotic | Grant | 0 |
3/2020 | AngioCloud | Grant | 0 |
3/2020 | Neovaccine Strategies | Grant | 0 |
2/2020 | Focused Cryo | Grant | 0 |
2/2020 | Focused Cryo | Grant | 0 |
1/2020 | Nyra Medical | Grant | 0 |
1/2020 | BioData Consortium | Grant | 0 |
12/2019 | Focused Cryo | Grant | 0 |
11/2019 | PNP Therapeutics | Grant | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|